Skip to Main Content

Paper Details

Divalent siRNAs are bioavailable in the lung and efficiently block SARS-CoV-2 infection.
Proc Natl Acad Sci U S A
8
2023
SARS, SARS-, SARS-CoV, SARS-CoV-2, SARS-CoV-2 genome, cell culture, cellular reporter, divalent siRNAs, human, human cells, mouse, multimeric siRNAs, siRNAs
Author NameAffiliation
Mohan SomasundaranUniversity of Massachusetts Chan Medical School
David A CooperRNA Therapeutics Institute, University of Massachusetts Chan Medical School
Zachary KennedyRNA Therapeutics Institute, University of Massachusetts Chan Medical School
Yang WangUniversity of Massachusetts Chan Medical School
Guangping GaoUniversity of Massachusetts Chan Medical School
Guangping GaoLi Weibo Institute for Rare Diseases Research, University of Massachusetts Chan Medical School
Guangping GaoUniversity of Massachusetts Chan Medical School
Dmitry KorkinWorcester Polytechnic Institute
Dmitry KorkinWorcester Polytechnic Institute
Katherine A FitzgeraldUniversity of Massachusetts Chan Medical School
Katherine A FitzgeraldLi Weibo Institute for Rare Diseases Research, University of Massachusetts Chan Medical School
Anastasia KhvorovaRNA Therapeutics Institute, University of Massachusetts Chan Medical School
  • 1 - 12

Datasets

Release 1.2